Controlled Trial With Deep Brain Stimulation in Patients With Early Parkinson's Disease
Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Earlystim Study: Patients are randomized either to medical treatment or subthalamic
stimulation. The observation period was 2 years. The primary outcome criterium: PDQ-39.
Post study Follow up studies: After the 24 months observation period also BMT patients could
be operated and all patients will be observed for 10 years or longer to elucidate whether
earlier stimulation has advantages (or drawbacks) compared to later stimulation.
Phase:
Phase 4
Details
Lead Sponsor:
German Parkinson Study Group (GPS)
Collaborators:
Assistance Publique - Hôpitaux de Paris KKS Netzwerk University Hospital Schleswig-Holstein